Join us at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium, which offers the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care.
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
1 event,
Join us at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium, which offers the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care. |
0 events,
|
||
|
4 events,
Leading investor conference that connects private and micro-mid-cap biotech companies with investors and biopharma executives, providing a platform to showcase their innovations and facilitate one-on-one meetings. BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week. This premier conference is the largest and most informative healthcare investment symposium in the industry, which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. The RESI Conference will be held on January 12-13 at the San Francisco Marriott Marquis, featuring two days in-person event followed by three days (January 14, 19&20) of online partnership activities. Previous RESI JPM conferences have drawn over a thousand attendees, including more than 500 early-stage life science investors, innovators, and industry experts. This RESI […] |
5 events,
The pharma and biotech industries stand at an inflection point unseen since the genomic revolution. After years of pandemic-fueled growth and subsequent market turmoil, companies are redefining how they will survive and thrive. Capital is scarcer. Regulators worldwide are rewriting the rules. Breakthrough therapies in oncology, rare diseases and obesity are upending competition, even as […] |
0 events,
|
0 events,
|
0 events,
|
||
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|